Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG

---

Publications & Presentations

61. Allen H C, Garbeb M C, Lees J, Azizb N, Chaaban H, Miller J L, Johnson P N, DeLeon S. Off-label drug use in children, more common than we think: A systematic review of the literature. Journal of Oklahoma State Medical Association. 2018; 10 : 758-765

62. Dannelley J F, Johnson P N, Anderson M P, Oestreich K, Siatkowski R M, Miller J L. Assessment of Outcomes With a Sedation Protocol During Laser Photocoagulation in Preterm Infants With Retinopathy of Prematurity. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2018; 23 : 410-416

63. Dannelley J F, Johnson P N, Anderson M, Oestreich K, Siatkowski R M, Miller J L. Assessment of Outcomes With a Sedation Protocol During Laser Photocoagulation in Preterm Infants With Retinopathy of Prematurity. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2018; 23 : 410-416

64. Medina M, Schwier N C, Miller J L, Miller M M, Skrepnek G H. Career Skills Assessment in a Doctor of Pharmacy Curriculum. American journal of pharmaceutical education. 2018; 82 : 6300

65. Johnson P N, Gildon B, Condren M, Miller J L, Hagemann T M, Lewis T V, John B, Farmer K. Description of a pediatric degree option program in a doctorate of pharmacy curriculum and its impact on pediatric-focused advanced pharmacy practice experience rotations and faculty scholarly productivity. Currents in pharmacy teaching & learning. 2018; 10 : 627-636

Grants

1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.

Awards and Honors

1. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.


2. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.


3. Pediatric Pharmacy Association. Christensen Memorial Young Investigator Award Nominee (Resident Mentor). Date: 2022.


4. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2019.


5. University of Oklahoma College of Pharmacy; Department of Clinical and Administrative Sciences. Best Paper Award. Date: 2018.

Education

1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.


2. Degree: BS. Trevecca Nazarene University. Date: 2002.

Administrative Assignments

1. Role: Department Vice-Chair. Scope: Department. Date: 2021.

Read More